Drag a card by its title · ⚙ to size, swap or remove

The company

Vir Biotechnology, Inc.

VIR · Nasdaq

Health CareBiotechnologyIn trend

VIR stood above a rising 150-day average in 44 of the last 52 weekly readings, including each of the last 10 weeks. It is 1.6% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: In trend
Weeks in an uptrend: 10 in a row
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $15.7M
Officials’ trades on record: 0
Institutions holding: 219 (-13)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 44 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months41

Buyers · sellers0 · 10

Who	Did	Shares	Traded
Brent SabatiniSVP, Chief Accounting Officer	sold	379at $9.45	1 Jun 2026filed 2 Jun 2026
Janet NapolitanoDirector	sold	3,200at $9.45	1 Jun 2026filed 2 Jun 2026
Vicki L. SatoDirector	sold	22,000at $10.05	1 May 2026filed 4 May 2026
Backer Marianne DePresident and CEO	sold	72,559at $9.16	6 Apr 2026filed 7 Apr 2026
Vicki L. SatoDirector	sold	22,000at $9.07	1 Apr 2026filed 2 Apr 2026
Brent SabatiniSVP, Chief Accounting Officer	sold	7,711at $9.12	23 Mar 2026filed 24 Mar 2026
Vicki L. SatoDirector	sold	21,800at $9.50	2 Mar 2026filed 3 Mar 2026
Vicki L. SatoDirector	sold	200at $9.98	2 Mar 2026filed 3 Mar 2026
Verneuil Vanina DeEVP, General Counsel, Corp Sec	sold	13,700at $9.82	25 Feb 2026filed 26 Feb 2026
Mark EisnerEVP and Chief Medical Officer	sold	1,889at $9.82	25 Feb 2026filed 26 Feb 2026
Backer Marianne DeChief Executive Officer	sold	14,762at $9.53	24 Feb 2026filed 26 Feb 2026
Verneuil Vanina DeEVP, General Counsel, Corp Sec	sold	3,117at $9.53	24 Feb 2026filed 26 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders219-13 on the quarter

New · exited31 · 44

Reported value$1.5B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	20,678,283$210.7M	+2,679,954+14.9%
ARCH Venture Management, LLCreduced · filed 14 Aug 2026	12,694,163$129.4M	-222,500−1.7%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	11,495,215$117.1M	+2,279,638+24.7%
SB INVESTMENT ADVISERS (UK) LTDunchanged · filed 14 Aug 2026	10,948,093$111.6M	00.0%
STATE STREET CORPadded · filed 7 Aug 2026	9,964,151$101.5M	+2,823,057+39.5%
GSK plcunchanged · filed 13 Aug 2026	8,550,954$87.1M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	6,388,775$65.1M	+1,006,672+18.7%
Point72 Asset Management, L.P.added · filed 14 Aug 2026	5,666,821$57.7M	+3,714,587+190.3%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	3,348,366$34.1M	+690,523+26.0%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026	3,119,421$31.8M	+539,743+20.9%